We are discovering game-changing medicines for diseases like cancer.
Discovering new medicines is extremely difficult and most traditional methods fail. We have a breakthrough technology which overcomes this hurdle – revolutionising drug development. Early work, funded by Johnson&Johnson, has shown an unprecedented 90% success rate in discovering lead medicines.
We are using this breakthrough to develop a treatment for bowel cancer – a debilitating disease worth billions of pounds annually.
Connect with DJS Antibodies